Japan Reviews GSK’s Bepirovirsen for Hepatitis B
GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a new drug application for bepirovirsen, an investigational antisense oligonucleotide (ASO) designed to treat adults living with chronic hepatitis B ( …